Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,822,000 | -3,561,000 | -4,714,000 | 8,362,000 | 12,202,000 |
| Depreciation Amortization | 148,000 | 94,000 | 560,000 | 379,000 | 286,000 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -318,000 |
| Accounts receivable | 156,000 | 534,000 | 493,000 | 1,790,000 | -1,784,000 |
| Accounts payable and accrued liabilities | -92,000 | -69,000 | 13,000 | 240,000 | 204,000 |
| Other Working Capital | 233,000 | -78,000 | 689,000 | -4,014,000 | 1,308,000 |
| Other Operating Activity | 504,000 | 76,000 | -159,000 | -1,776,000 | 1,722,000 |
| Operating Cash Flow | $-1,873,000 | $-3,004,000 | $-3,118,000 | $4,981,000 | $13,620,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -192,000 | -1,051,000 | -707,000 | -400,000 | -284,000 |
| Net Acquisitions | N/A | N/A | -85,000 | N/A | N/A |
| Purchase Of Investment | -5,768,000 | -6,529,000 | -3,783,000 | -11,475,000 | -12,682,000 |
| Sale Of Investment | 7,916,000 | 9,529,000 | 8,781,000 | 6,699,000 | 4,443,000 |
| Purchase Sale Intangibles | -10,000 | 0 | 0 | N/A | N/A |
| Other Investing Activity | -10,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $1,946,000 | $1,949,000 | $4,206,000 | $-5,176,000 | $-8,523,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 600,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 35,000 | 66,000 | 46,000 | 65,000 | 124,000 |
| Common Stock Repurchased | N/A | N/A | N/A | -3,329,000 | -857,000 |
| Other Financing Activity | -42,000 | -10,000 | -1,423,000 | -184,000 | -140,000 |
| Financing Cash Flow | $593,000 | $56,000 | $-1,377,000 | $-3,448,000 | $-873,000 |
| Exchange Rate Effect | 2,000 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 1,929,000 | 2,928,000 | 3,217,000 | 6,860,000 | 2,636,000 |
| End Cash Position | 2,597,000 | 1,929,000 | 2,928,000 | 3,217,000 | 6,860,000 |
| Net Cash Flow | $668,000 | $-999,000 | $-289,000 | $-3,643,000 | $4,224,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,873,000 | -3,004,000 | -3,118,000 | 4,981,000 | 13,620,000 |
| Capital Expenditure | -192,000 | -1,051,000 | -707,000 | -400,000 | -284,000 |
| Free Cash Flow | -2,065,000 | -4,055,000 | -3,825,000 | 4,581,000 | 13,336,000 |